Published in Women's Health Weekly, October 12th, 2006
The database - more than 2,000 patient samples from the last five years used to identify more than 500 protein biomarkers - represents the platform for Power3's patent-pending proteomic testing and biomarker discovery methods for early detection, monitoring and staging of a broad range of diseases, including breast cancer, Alzheimer, Parkinson, ALS (Lou Gehrig's disease) and other neurodegenerative diseases.
"The database offers a broad spectrum of patient samples from our proteomic research," said Silvia Quintero of Power3's scientific team....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly